-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Antiphospholipid Syndrome: Still an Enigma

Program: Education Program
Session: Challenging Scenarios in Thrombosis
Saturday, December 5, 2015, 7:30 AM-9:00 AM
W311, Level 3 (Orange County Convention Center)
Sunday, December 6, 2015, 9:30 AM-11:00 AM
W224, Level 2 (Orange County Convention Center)

Keith McCrae

Cleveland Clinic, Cleveland, OH

Disclosures: McCrae: Janssen Scientific Affairs: Membership on an entity’s Board of Directors or advisory committees . Off Label Use: Rituximab.

See more of: Challenging Scenarios in Thrombosis
See more of: Education Program
<< Previous Presentation | Next Presentation >>